Stempoint Capital’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-86,930
Closed -$5.05M 62
2024
Q3
$5.05M Buy
+86,930
New +$5.05M 1.51% 20